AstraZeneca: Recentin Not Better Vs Rival In Trial
Read »AstraZeneca: Recentin Not Better Vs Rival In Trial
Created by 2cool
– Made popular 1 year 48 weeks ago
Upcoming Stories
- 1Rentenbank Sets Guidance On EUR500 Million 7-Year Bond At Swaps +0.04
- 1Orange Switzerland Prices EUR180 Million Tap Of 2019 FRN At Par
- 1Gazprom Forecasts 4Q11 Revenue At $40.4 Billion
- 1Tata Chemicals Oct-Dec Net Profit Up 36% On Higher Sales Volume, Prices
- 1CFF Revises Guidance On 2015 Covered Bond To Swaps +0.95-1.00
- 1Polish Treasury: State Firms Should Team Up For Shale Gas Search
- 1IEA: Slashes 2012 Oil Demand Growth On Weaker Economy